Yesterday I helped launch the #C4CT cause via the blog and twitter and it was nice to see the interest really begin to peak (thanks @SchuttSports, @the_jockdoc and many others). As with most movements or introduction of products getting interest is the first thing; now with official press release in hand it is time to explain and get more of us going here.
The hard work of Jack Brewer and Alex Nennig (and probably others) of Brewer Sports International have created this coalition which I believe to be a “best foot forward” approach in not only raising awareness and education of concussions (our number on goal on The Concussion Blog) but has a possibility to stake a claim in treatment of lasting effects of TBI. I am honored to be asked to be a primary supporter of this cause, although as it catches wild-fire I am hopeful more important people jump aboard – looking at you NFLPA and NFL.
It is also an honor to be along side a very strong and promising law student in Paul Anderson. I have had many conversations about creating such a cause, but have yet to find the trailblazing counterparts until this came along. Please take the time to read the below press release and join along this weekend in using the #C4CT, even promoting questions from others about the hash tag is an opportunity to inform!
Brewer Sports International launches
#C4CT to raise awareness for concussion treatments
Coalition for Concussion Treatment (#C4CT) to highlight the importance of increasing awareness
and support of developing new treatments for traumatic brain injury
MINNEAPOLIS, MN– April 26, 2012 – Brewer Sports International (BSI), a globally diversified boutique services provider for professional athletes, sports agencies and numerous other international organizations touching the sports and wellness field, today announced the launch of a new movement called the “Coalition for Concussion Treatment”. Referred by the twitter shorthand #C4CT, the purpose of the coalition is to continue building awareness about key scientific and medical advances in an ongoing effort to identify and develop new Traumatic Brain Injury (TBI) treatment opportunities.
“With recent developments in the actions of the NFL, NCAA and youth sports leagues around the country changing their long-standing rules and practices as it relates to concussions, there is clearly a major shift in mentality when it comes to the acceptance of impact these injuries have on players” said Jack Brewer, CEO of Brewer Sports International, former football player with the University of Minnesota and five-year veteran of the National Football League (NFL). “It is critical for those of us who have first-hand experience with concussions and who can influence change by accelerating research to take a leadership role to make our peers and the community at large aware of the potential of new research in development. This could have a big impact for future generations of players having access to better care.”
With numerous NFL alumni suffering from mild to severe effects from concussions, the lack of treatment for brain injuries has yet to come to fruition. As of today, nearly 2,000 former and current NFL players have stepped forward to raise awareness of the severity of this issue and the need for a solution, and that number is continuing to grow. During his five-year career in the NFL, CEO Jack Brewer has firsthand knowledge on the devastating effects of concussions.
“As an ex-NFL player I personally have experienced hundreds of violent collisions throughout my career and also have several teammates and friends who suffer the lasting effects of traumatic brain injuries,” continued Mr. Brewer. “This is a passion of mine and BSI is committed to helping advance TBI research and development. I am hopeful that our ongoing support and this coalition will help raise awareness and establish new technology for the treatment of brain injuries and concussions.”
In November 2011, Brewer Sports International funded research being conducted under a collaboration agreement between Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF), a first-in-class disease–modifying therapeutic protein, and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect concussions and other forms of TBI as they work to develop innovative treatment methods for traumatic brain injuries.
The BSI Coalition for Concussion Treatment has garnered the support of Paul Anderson, an aspiring attorney who runs the most comprehensive legal website covering all lawsuits filed against the NFL regarding concussions known as NFL Concussion Litigation. In addition, Dustin Fink a certified athletic trainer (ATC) who administers a website covering concussions and their treatment known as The Concussion Blog is actively supporting the movement.
A #C4CT online petition has also been established. For more information and to join the movement, visit:
About the Coalition for Concussion Treatment
The “Coalition for Concussion Treatment” was created behind the concept of creating a viral campaign through twitter and various digital and social media outlets to help ignite awareness of the severity of concussions and enhance treatment efforts using the hash tag #C4CT.
About Brewer Sports International, LLC
Brewer Sports International (BSI) offers a boutique of sports lending, corporate advisory and entertainment services for professional athletes, sports agencies, public and private corporations and various partners including international organizations, governments and NGOs. BSI was founded by Jack Brewer, a five-year National Football League (NFL) veteran and former team captain on three NFL teams. Additionally, BSI has created a unique financial services platform that is offered to professional athletes and sports agencies, as well as high net worth individuals and businesses touching professional sports. BSI takes pride in building value for its clients through sports and entertainment. For more information, please visit www.brewersports.com.
About Amarantus BioSciences, Inc.
Amarantus BioSciences, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat Parkinson’s disease, Traumatic Brain Injury and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”) and is developing MANF-based products as treatments for human disorders. For further information please visit www.amarantus.com.
About Paul Anderson
Paul D. Anderson is a third-year law student at the University of Missouri-Kansas City. He is focusing on Sports Law, Class Actions, Labor & Employment Law and Business Litigation. He clerked with the law firm of Monaco, Sanders, Gotfredson, Racine and Barber, and last summer, interned with Senior U.S. District Judge Ortrie D. Smith at the United States District Court of the Western District of Missouri. Paul turned his attention to the current litigation battle heating up in football regarding concussions. For more information please visit http://www.nflconcussionlitigation.com.
About Dustin Fink
Dustin Fink is a certified athletic trainer (ATC) working in Central Illinois. His experience with concussions and TBI in athletics extends 12+ years as a professional, and another 8 as either a student athletic trainer or athlete himself. Having sustained multiple concussions and beginning to feel the effects years later, while also seeing kids at the high school level report concussions on a more frequent rate, this has become his passion.
For more information please visit www.theconcussionblog.com.